missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STK17A (DRAK1) Recombinant Human Protein
STK17A (DRAK1) Recombinant Human Protein
Marca: Invitrogen PV3783
Detalles adicionales : Peso : 0.05250kg
Descripción
STK17A (DRAK1) is a serine⁄threonine kinase localized in the nucleus and involved in apoptosis.Especificaciones
| NP_004751 | |
| Cell Viability, Pharma and Biopharma, Cell Proliferation and Function, Protein Assays and Analysis, Target and Lead Identification and Validation, Kinase Assay | |
| 74kDa | |
| 10μg | |
| For research use only. Not for use in diagnostic procedures | |
| STK17A (DRAK1) | |
| STK17A (DRAK1) was pre-diluted in enzyme dilution buffer and assayed in 25mM Tris (pH 7.5), 10mM MgCl2, 0.5mM EGTA, 0.5mM Na3VO4, 5mM β-glycerophosphate, 5mM DTT, 0.01% Triton™ X-100, 100μM ATP, 290μg/mL MLCK peptide substrate (KKRAARATSDVFA-NH2) and trace [32P]-γ-ATP for 10 minutes at 30°C | |
| STK17A (DRAK1) Recombinant Human Protein | |
| Human | |
| Baculovirus | |
| Serine/threonine kinase |
| 0.25mg/mL | |
| 554, 9263 | |
| STK17A (DRAK1) Recombinant Human Protein | |
| –80°C | |
| 1 Each | |
| STK17A (DRAK1) Recombinant Human Protein | |
| DAPK | |
| 36nmoles of phosphate transferred to MLCK peptide substrate (KKRAARATSDVFA-NH2) per minute per mg of total protein at 30°C. Activity determined at a final protein concentration of 8.33μg/mL | |
| GST Tag | |
| Kinase and inhibitors | |
| 75% by SDS-PAGE |
For Research Use Only. Not for use in diagnostic procedures.